Horizon Therapeutics PLC expected to post earnings of $1.12 a share - Earnings Preview

Horizon Therapeutics

04/08/2023 08:33

* Horizon Therapeutics PLC  HZNP.OQ   HZNP.O  is expected
to show
a rise in quarterly revenue when it reports  results on August
8. 
    * The Dublin-based  company is expected to report  a
2.3% increase
in revenue to $896.359 million from $876.41 million a year ago,
according to the mean estimate from 4 analysts, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Horizon
Therapeutics PLC
is for earnings of $1.12 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Horizon
Therapeutics PLC is $116.5​, above​ its last closing price
of $98.98. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  1.24        1.12       0.83      Missed  -25.9
 Dec. 31 2023  1.09        1.09       1.21      Beat    11
 Sep. 30 2022  1.02        1.01       1.25      Beat    23.9​
 Jun. 30 2022  1.31        1.34       1.07      Missed  -20.2
 ​​Mar.        1.13        1.14       1.34      Beat    17.5
 31 2022                                                
 Dec. 31 2021  1.32        1.35       1.41      Beat    4.8​
 Sep. 30 2021  1.54        1.54       1.75      Beat    13.9
 Jun. 30 2021  0.89        0.88       1.62      Beat    83.8
 This summary was machine generated August 4 at 07:33 GMT.  All
figures in US dollars  unless otherwise stated